{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:12Z","timestamp":1783595172385,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.ajkd.2011.07.024","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T14:51:34Z","timestamp":1318258294000},"page":"284-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["New Insights Into Human Minimal Change Disease: Lessons From Animal Models"],"prefix":"10.1053","volume":"59","author":[{"given":"Sumant S.","family":"Chugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel C.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2011.07.024_bib1","series-title":"The Kidney","first-page":"987","article-title":"Primary glomerular disease","author":"Nachman","year":"2008"},{"issue":"3","key":"10.1053\/j.ajkd.2011.07.024_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.2008.260","article-title":"Glomerular filtration: the charge debate charges ahead","volume":"74","author":"Miner","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2011.07.024_bib3","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases","volume":"296","author":"Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4200","key":"10.1053\/j.ajkd.2011.07.024_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.1145209","article-title":"Glomerular epithelium: structural alterations induced by polycations","volume":"189","author":"Seiler","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib5","first-page":"48","article-title":"Pathogenesis of polycation-induced alterations (\u201cfusion\u201d) of glomerular epithelium","volume":"36","author":"Seiler","year":"1977","journal-title":"Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2011.07.024_bib6","first-page":"224","article-title":"Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier","volume":"124","author":"Daniels","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1053\/j.ajkd.2011.07.024_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1523-1755.2001.059002601.x","article-title":"Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum","volume":"59","author":"Chugh","year":"2001","journal-title":"Kidney Int"},{"issue":"51","key":"10.1053\/j.ajkd.2011.07.024_bib8","doi-asserted-by":"crossref","first-page":"39681","DOI":"10.1074\/jbc.M606664200","article-title":"ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"issue":"7880","key":"10.1053\/j.ajkd.2011.07.024_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2011.07.024_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.ki.5002302","article-title":"Early changes in gene expression that influence the course of primary glomerular disease","volume":"72","author":"Clement","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2011.07.024_bib13","doi-asserted-by":"crossref","unstructured":"Abraham P, Isaac B. Ultrastructural changes in the rat kidney after single dose of cyclophosphamide\u2014possible roles for peroxisome proliferation and lysosomal dysfunction in cyclophosphamide induced renal damage [published online ahead of print March 18, 2011]. Hum Exp Toxicol. doi: 10.1177\/0960327111402240.","DOI":"10.1177\/0960327111402240"},{"issue":"5","key":"10.1053\/j.ajkd.2011.07.024_bib14","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2011.07.024_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","article-title":"Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase","volume":"43","author":"Yoshida","year":"2002","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1053\/j.ajkd.2011.07.024_bib17","first-page":"649","article-title":"Glomerular polyanion","volume":"23","author":"Michael","year":"1970","journal-title":"Lab Invest"},{"issue":"11","key":"10.1053\/j.ajkd.2011.07.024_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/01.RES.0000250758.63358.91","article-title":"Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton","volume":"99","author":"Cazes","year":"2006","journal-title":"Circ Res"},{"issue":"10","key":"10.1053\/j.ajkd.2011.07.024_bib19","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1074\/jbc.M212127200","article-title":"GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism","volume":"278","author":"Luchansky","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat Genet"},{"issue":"22","key":"10.1053\/j.ajkd.2011.07.024_bib21","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddm220","article-title":"AGne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1053\/j.ajkd.2011.07.024_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nm.1956","article-title":"Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model","volume":"15","author":"Malicdan","year":"2009","journal-title":"Nat Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.07.024_bib23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI30954","article-title":"Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine","volume":"117","author":"Galeano","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2011.07.024_bib24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1083\/jcb.98.4.1591","article-title":"Identification and characterization of podocalyxin\u2014the major sialoprotein of the renal glomerular epithelial cell","volume":"98","author":"Kerjaschki","year":"1984","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.07.024_bib25","first-page":"343","article-title":"Reduced sialylation of podocalyxin\u2014the major sialoprotein of the rat kidney glomerulus\u2014in aminonucleosidenephrosis","volume":"118","author":"Kerjaschki","year":"1985","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1053\/j.ajkd.2011.07.024_bib26","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1073\/pnas.88.12.5398","article-title":"Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits","volume":"88","author":"Dekan","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1053\/j.ajkd.2011.07.024_bib27","first-page":"907","article-title":"In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury","volume":"74","author":"Gelberg","year":"1996","journal-title":"Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2011.07.024_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI12539","article-title":"Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton","volume":"108","author":"Takeda","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2011.07.024_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.194.1.13","article-title":"Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin","volume":"194","author":"Doyonnas","year":"2001","journal-title":"J Exp Med"},{"issue":"2","key":"10.1053\/j.ajkd.2011.07.024_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.07.024_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611013060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611013060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:57:46Z","timestamp":1759456666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638611013060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0272638611013060"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.07.024","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights Into Human Minimal Change Disease: Lessons From Animal Models","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}